摘要:
The present invention relates to a 1,8-naphthyridine derivative of the formula wherein R 1 , R 2 and R 3 are the same or different and each hydrogen or lower alkyl having 1 to 5 carbon atoms; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.
摘要:
Novel acetic acid derivatives of the formula: wherein X is oxygen or sulfur; R, is hydrogen or a lower alkyl; R 2 is hydroxy, an alkoxy, an alkenyloxy, a cycloalkyloxy, an aryloxy, a substituted aryloxy, an aryl-lower alkoxy, a substituted aryl-lower alkoxy, an aryl-lowrer alkenyloxy, a substituted aryl-lower alkenyloxy, an ω-di-substituted amino-lower alkoxy, a lower alkoxycarbonyl-lower alkoxy, a lower alkoxy-lower alkoxy, a hydroxy-lower alkoxy-lower alkoxy, an acyl-lower alkoxy, or a group wherein R 3 is hydrogen, hydroxy, a lower alkyl, an aryl-lower alkyl, a hydroxy-lower alkyl, or a carboxy-lower alkyl, R 4 is hydrogen, a lower alkyl or a hydroxy-lower alkyl, or the R 3 and R 4 may combine together with the nitrogen atom to which they are joined to form a heterocyclic group; and the group -CH(R 1 )COR 2 is joined to the carbon atom at 2- or 3-position, and pharmaceutically acceptable salts thereof have excellent anti-inflammatory, analgesic and antipyretic activities with weak ulcerogenicity in the gastrointestinal tract and toxicity. They can be prepared by cyclization reaction and made up into pharmaceutical compositions.
摘要:
The invention relates to novel 4-(2'-pyridylamino) -phenylacetic acid derivatives of the formula I
Wherein R 1 is hydrogen, a halogen, a lower alkyl having 1 to 3 carbon atoms, or nitro, R 2 is hydrogen, a halogen, or a lower alkyl having 1 to 3 carbon atoms, R 3 is hydrogen, a halogen, or a lower alkyl having 1 to 3 carbon atoms, R 4 is hydrogen or a lower alkyl having 1 to 3 carbon atoms, R s is hydrogen or-CH 2 CH 2 OR 6 wherein R 6 is lower alkyl having 2 or 3 carbon atoms and being substituted with 1 or 2 hydroxy groups, provided that R 1 or R 2 is not 4-halogen, or pharmaceutically acceptable salts thereof, a process fortheir preparation (e.g.2-[4-(2'-pyridylamino)pehnyl] propionic acid (compound A) is prepared by reacting methyl 2-(4-amino -phenyl)propionate with 2-chloropyridine, followed by hydrolysis), pharmaceutcial composition containing these compounds, and their use as anti-inflammatory and analgesic agents. They have excellent anti-inflammatory and analgesic activities with an extremely weak ulcerogenicity in the gastrointestinal tract. Some of the compounds have superior inhibitory activity against chronic inflammation mediated by cellular immunity. In the figure the prophylactic effect on adjuvant-induced arthritis in rats is shown (vehicle control (line 1), reference compound Ibuprofen (line 2), new compound A (line 3)].
摘要:
Compounds of the formula: wherein X is alkylene or-(CR 6 -CR 7 ) r - wherein R 6 is H, alkyl or phenyl, R 7 is H, alkyl, cyano or phenyl, and r is 1 or 2; A is alkylene or alkylene interrupted by at least one double bond; R 1 is H, halogen, alkyl, alkoxy, alkylthio, cycloalkyloxy, cycloa-Ikylthio, alkoxycarbonyl, carboxy, phenyl, phenoxy, phenylthio, 3-pyridyloxy or 3-pyridylthio; R 2 is H, hydroxy, alkanoyloxy or alkoxycarbonyloxy, or adjacent R, and R 2 may combine to form tetramethylene or-CH 2 OCR 8 R 9 O-(R 8 and Rg are alkyl); R 3 is H, alkyl or hydroxyalkyl; R 4 is H or alkyl; R 5 is phenyl, heteroaryl or-(CH 2 ) m -CHR 10 R 11 (R 10 is H or phenyl, R 11 is phenyl or pyridyl and m is 0 to 2); p is 0 or 1; and q is 2 or 3; the phenyl group or moiety being optionally substituted, and salts thereof show excellent antiallergic activity mainly through 5-lipoxygenase inhibiting activity, antihistamine activity and/or inhibitory activity against chemical mediator release and are useful for treatment of allergic diseases. Processes for their preparation and pharmaceutical compositions containing them are also described.
摘要:
Compounds of the formula: wherein X is alkylene or-(CR 6 -CR 7 ) r - wherein R 6 is H, alkyl or phenyl, R 7 is H, alkyl, cyano or phenyl, and r is 1 or 2; A is alkylene or alkylene interrupted by at least one double bond;
R 1 is H, halogen, alkyl, alkoxy, alkylthio, cycloalkyloxy, cycloa-Ikylthio, alkoxycarbonyl, carboxy, phenyl, phenoxy, phenylthio, 3-pyridyloxy or 3-pyridylthio; R 2 is H, hydroxy, alkanoyloxy or alkoxycarbonyloxy, or adjacent R, and R 2 may combine to form tetramethylene or-CH 2 OCR 8 R 9 O-(R 8 and Rg are alkyl); R 3 is H, alkyl or hydroxyalkyl; R 4 is H or alkyl; R 5 is phenyl, heteroaryl or-(CH 2 ) m -CHR 10 R 11 (R 10 is H or phenyl, R 11 is phenyl or pyridyl and m is 0 to 2); p is 0 or 1; and q is 2 or 3; the phenyl group or moiety being optionally substituted, and salts thereof show excellent antiallergic activity mainly through 5-lipoxygenase inhibiting activity, antihistamine activity and/or inhibitory activity against chemical mediator release and are useful for treatment of allergic diseases. Processes for their preparation and pharmaceutical compositions containing them are also described.
摘要:
The present invention relates to a 1,8-naphthyridine derivative of the formula wherein R 1 , R 2 and R 3 are the same or different and each hydrogen or lower alkyl having 1 to 5 carbon atoms; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.
摘要:
1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-propanone and its pharmaceutically acceptable acid addition salts, which are useful as centrally acting muscle relaxants in the treatment of spasticity in mammals including humans, process for the preparation thereof, and pharmaceutical composition containing said compound as an active ingredient.